Risk Factors
HIGH
18A Process Node ExecutionIntel's turnaround depends on Intel 18A being competitive with TSMC's N2 node. Any yield, performance, or timeline miss on 18A would validate the thesis that Intel cannot recover its manufacturing leadership.
HIGH
Continued Server CPU Share LossAMD EPYC continues to win server contracts. If Intel can't stop the share bleed with Granite Rapids and Clearwater Forest, the most profitable segment continues to shrink.
HIGH
AI Silicon AbsentIntel's Gaudi AI accelerator has not achieved meaningful market share against NVIDIA H100/H200 or even AMD Instinct MI300X. Missing the AI silicon wave is an existential challenge for a chip company in 2026.
MED
Foundry Customer AcquisitionIntel Foundry Services needs marquee customer wins to justify the $100B fab buildout. Without major fabless customers (Apple, Qualcomm, NVIDIA) committing to Intel fabs, IFS economics don't work.
MED
Balance Sheet Stress$12B losses + $25B capex = severe cash burn. Without CHIPS Act funding materializing on schedule, Intel may need dilutive equity raises or asset sales.